Sources: Dassault Systèmes is in talks to buy drug trial software maker ArisGlobal from Nordic Capital for about $2B, extending its push into life sciences (Financial Times)
retained text
Techmeme permalink: https://www.techmeme.com/260716/p62#a260716p62 <a href="https://www.ft.com/content/72c335dd-11c9-4ba0-bd11-41414df06d97"><img align="RIGHT" border="0" hspace="4" src="http://www.techmeme.com/260716/i62.jpg" vspace="4" /></a> <p><a href="https://www.techmeme.com/260716/p62#a260716p62" title="Techmeme permalink"><img height="12" src="http://www.techmeme.com/img/pml.png" style="border: none; padding: 0; margin: 0;" width="11" /></a> <a href="https://www.ft.com/">Financial Times</a>:<br /> <span style="font-size: 1.3em;"><b><a href="https://www.ft.com/content/72c335dd-11c9-4ba0-bd11-41414df06d97">Sources: Dassault Systèmes is in talks to buy drug trial software maker ArisGlobal from Nordic Capital for about $2B, extending its push into life sciences</a></b></span> — Potential purchase of ArisGlobal from Swedish buyout company would boost French conglomerate's push into life sciences</p>
document fetched 2026-07-17 07:57 · canonical https://ft.com/content/72c335dd-11c9-4ba0-bd11-41414df06d97